Development of mid-size molecule inhibitors of VIPR2 for the treatment of psychiatric disorders

○Yukio Ago

[26P2-pm1-021] Development of mid-size molecule inhibitors of VIPR2 for the treatment of psychiatric disorders

○Yukio Ago¹, Mei Yamada², Tatsunori Miyaoka², Lu Chen², Kenji Ishimoto², Nobumasa Hino², Shinsaku Nakagawa², Kotaro Sakamoto³, Satoshi Asano¹ (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 3. Ichimaru Pharcos Co. Ltd.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[26P2-pm1] Pharmacology 1

[26P2-pm1-021] Development of mid-size molecule inhibitors of VIPR2 for the treatment of psychiatric disorders

Password